ROCKVILLE, Md., Feb. 11, 2020 /PRNewswire/ — The Institute for Bioscience and Biotechnology Research (IBBR) is accepting proposals to lease a bio-manufacturing facility configured to produce biologicals under cGMP conditions in compliance with FDA requirements for phase I/II clinical trials. The facility is also equipped to perform process development research, pre-clinical manufacturing for material necessary to conduct IND-enabling toxicology studies, proof of concept (POC) studies, and process demonstration in advance of Good Manufacturing Practices (GMP) manufacturing. IBBR is a joint research enterprise between the University of Maryland and the National Institute of Standards and Technology (NIST).
Image: IBBR is strategically located in Rockville, MD within easy reach of major academic, industry, and federal research laboratories, including the University of Maryland campuses, NIST, NIH, FDA, NCI, and USDA. By Institute for Bioscience and Biotechnology Research